NFE2L2 and myocardial infarction: Studies have shown that wogonin263, hirudin264, dapsone226, and rosuvastatin combined with low-dose carvedilol265 all act on the NRF2/HO-1 pathway to protect cardiomyocytes from oxidative stress damage after MI and reduce cardiomyocyte apoptosis.